BioCentury | Sep 25, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Various Type 2 diabetes; HIV/AIDS a-glucosidase An SAR study characterized a series of mono- and diketal, and mono- and diacetal derivatives...
BioCentury | Jan 19, 2004
Finance

Ebb & Flow

...in drug delivery company Alexza ; engineered protease developer Catalyst Biosciences; plant-based gene expression company Chlorogen...
BioCentury | Jan 12, 2004
Financial News

Burrill closes $211M fund

...drug delivery company Alexza Molecular; engineered protease developer Catalyst Biosciences ; plant-based gene expression company Chlorogen...
Items per page:
1 - 3 of 3
BioCentury | Sep 25, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Various Type 2 diabetes; HIV/AIDS a-glucosidase An SAR study characterized a series of mono- and diketal, and mono- and diacetal derivatives...
BioCentury | Jan 19, 2004
Finance

Ebb & Flow

...in drug delivery company Alexza ; engineered protease developer Catalyst Biosciences; plant-based gene expression company Chlorogen...
BioCentury | Jan 12, 2004
Financial News

Burrill closes $211M fund

...drug delivery company Alexza Molecular; engineered protease developer Catalyst Biosciences ; plant-based gene expression company Chlorogen...
Items per page:
1 - 3 of 3